Literature DB >> 21076925

Obesity and oxidative stress: a direct link to preeclampsia?

Ana Bertha Zavalza-Gómez1.   

Abstract

Overweight is associated with alterations in lipid concentrations and an activation of inflammatory markers and both of these metabolic abnormalities are characteristic of preeclamptic pregnancies before the onset of clinically evident disease. Reactive oxygen species, particularly superoxide anions, evoke endothelial cell activation through many pathways. Markers of lipid peroxidation, including malondialdehyde and 8-epiprostaglandin-F2α, is increased in the plasma of women with preeclampsia, and the low concentrations of water- and lipid-soluble antioxidants in the plasma and the placenta further suggest a state of oxidative stress. This review focuses in the relation between maternal obesity, oxidative stress with development of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076925     DOI: 10.1007/s00404-010-1753-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  13 in total

1.  Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia.

Authors:  Roy M Nilsen; Anne-Lise Bjørke-Monsen; Oivind Midttun; Ottar Nygård; Eva R Pedersen; Arve Ulvik; Per Magnus; Håkon K Gjessing; Stein Emil Vollset; Per Magne Ueland
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

Review 2.  Pathophysiology and Current Clinical Management of Preeclampsia.

Authors:  Lorena M Amaral; Kedra Wallace; Michelle Owens; Babbette LaMarca
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

3.  Pregnancy weight gain may affect perinatal outcomes, quality of life during pregnancy, and child-bearing expenses: an observational cohort study.

Authors:  Ching-Chung Liang; Minston Chao; Shuenn-Dhy Chang; Sherry Yueh-Hsia Chiu
Journal:  Arch Gynecol Obstet       Date:  2021-03-04       Impact factor: 2.344

4.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

5.  Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries.

Authors:  Elizabeth Stankiewicz Machado; Margot R Krauss; Karen Megazzini; Conrado Milani Coutinho; Regis Kreitchmann; Victor Hugo Melo; José Henrique Pilotto; Mariana Ceriotto; Cristina B Hofer; George K Siberry; D Heather Watts
Journal:  J Infect       Date:  2014-01-23       Impact factor: 6.072

6.  Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

Review 7.  Oxidative stress in preeclampsia and the role of free fetal hemoglobin.

Authors:  Stefan R Hansson; Åsa Nääv; Lena Erlandsson
Journal:  Front Physiol       Date:  2015-01-13       Impact factor: 4.566

8.  Maternal obesity and energy intake as risk factors of pregnancy-induced hypertension among Iranian women.

Authors:  Elham Kazemian; Gity Sotoudeh; Ahmad Reza Dorosty-Motlagh; Mohammad Reza Eshraghian; Minoo Bagheri
Journal:  J Health Popul Nutr       Date:  2014-09       Impact factor: 2.000

9.  Preconception Cardiovascular Risk Factor Differences Between Gestational Hypertension and Preeclampsia: Cohort Norway Study.

Authors:  Grace M Egeland; Kari Klungsøyr; Nina Øyen; Grethe S Tell; Øyvind Næss; Rolv Skjærven
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

10.  Differential regional fatty acid distribution in normotensive and preeclampsia placenta.

Authors:  Alka Rani; Preeti Chavan-Gautam; Savita Mehendale; Girija Wagh; Sadhana Joshi
Journal:  BBA Clin       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.